DrugPatentWatch Database Preview
« Back to Dashboard
|Title:||Systematic evolution of ligands by exponential enrichment: Chemi-SELEX|
|Abstract:||This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.|
|Inventor(s):||Gold; Larry (Boulder, CO), Eaton; Bruce (Boulder, CO), Smith; Drew (Boulder, CO), Wecker; Matthew (Boulder, CO), Jensen; Kirk (Boulder, CO)|
|Assignee:||NeXstar Pharmaceuticals, Inc. (Boulder, CO)|
|Filing Date:||Jun 05, 1995|
|Claims:||1. Nucleic acid ligands which bind covalently with a protein, wherein said nucleic acid ligands comprise a chemically reactive functional unit selected from the group consisting of pohotoreactive groups and active site directed compounds, wherein said nucleic acid ligands are produced by a method comprising the steps of: |
a) preparing a candidate mixture of nucleic acids;
b) contacting said candidate mixture with said protein, wherein nucleic acids which bind covalently with said protein may be partitioned from the remainder of said candidate mixture;
c) partitioning the nucleic acid-protein complexes from free nucleic acids in said candidate mixture; and
d) identifying said nucleic acid ligands that bind covalently with said protein.
2. The nucleic acid ligands of claim 1 which are selected from the sequences listed in Tables II and IV.
3. The nucleic acid ligand of claim 1 wherein said nucleic acids comprise a fixed sequence region.
4. The nucleic acid ligand of claim 3 wherein at least one fuinctional unit is attached to an oligonucleotide hybridized to said fixed sequence region.
5. A purified and non-naturally occurring nucleic acid ligand which binds covalently with a protein, wherein said nucleic acid ligand comprises a chemically reactive functional unit selected from the group comprising photoreactive groups and active site directed compounds.